AHA Statement on Managing Pregnant Women With CVD
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Valvular Heart Disease
VALVULAR HEART DISEASE
Latest News
Elevated Risk for Aortic Valve Regurgitation in Ankylosing Spondylitis
Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.
Outcomes Similar After TAVR in Bicuspid, Tricuspid Anatomy
All-cause mortality and stroke are comparable at 30 days and one year after TAVR among patients with bicuspid and tricuspid valve stenosis.
ACC Expert Consensus Decision Pathway for Mitral Regurgitation Management: 2020 Update
The ACC published a focused update of the 2017 expert consensus decision pathway on the management of mitral regurgitation.
Baseline HDL-C and CRP Levels to Predict Mortality After TAVI
High CRP and low HDL-C levels at baseline were found to predict all-cause mortality in elderly patients who underwent TAVI.
NT-proBNP Ratio May Improve Prognosis in Elderly Patients With Valvular Heart Disease
The N-terminal pro–B-type natriuretic peptide ratio may improve prognosis in elderly patients with moderate to severe valvular heart disease.
TriClip Device May Be Safe and Effective at Reducing Tricuspid Regurgitation
The TriClip device may be safe and effective for lowering tricuspid regurgitation by 1 grade or more.
Factors Associated With Increased Risk for AVR, Death in Aortic Stenosis
Atrial fibrillation, left ventricular ejection fraction (LVEF), abnormal right ventricular function, and ventricular hypertrophy were found to be associated with a greater risk for aortic valve replacement (AVR), death, or hospitalization for heart failure in patients with moderate aortic stenosis, according to a study published in The American Journal of Cardiology. In this retrospective single-center study,…
Lipid-Lowering Therapy May Reduce Need for AVR in Mild Aortic Stenosis
Investigators examined whether pretreatment low-density lipoprotein cholesterol levels and aortic stenosis severity affect lipid-lowering therapy to decrease aortic valve replacement.
Fluoroquinolone Exposure Linked to Increased Left-Sided Valvular Regurgitation Risk
Fluoroquinolone antibiotic exposure was linked to an increased risk of developing left-sided valvular regurgitation.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Valvular Heart Disease
